Thoracic Oncology Laboratory »  Publications

Publications

View by Year:
 
Shi Y, He B, Kuchenbecker KM, You L, Xu Z, Mikami I, Yagui-Beltran A, Clement G, Lin YC, Okamoto J, Bravo DT, Jablons DM
Inhibition of Wnt-2 and galectin-3 synergistically destabilizes beta-catenin and induces apoptosis in human colorectal cancer cells.
International journal of cancer, Sep-15-2007;121(6):1175-81.
Shi Y, He B, You L, Jablons DM
Roles of secreted frizzled-related proteins in cancer.
Acta pharmacologica Sinica, Sep-2007;28(9):1499-504.
Raz DJ, Kim JY, Jablons DM
Diagnosis and treatment of bronchioloalveolar carcinoma.
Current opinion in pulmonary medicine, Jul-2007;13(4):290-6.
Raz DJ, Zell JA, Ou SH, Gandara DR, Anton-Culver H, Jablons DM
Natural history of stage I non-small cell lung cancer: implications for early detection.
Chest, Jul-2007;132(1):193-9.  Epub 2007 May 15.
Raz DJ, Jablons DM
EGFR expression and mutational analysis as a predictive test.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, May-20-2007;25(15):2144; author reply 2144-5.
Lee AY, Raz DJ, He B, Jablons DM
Update on the molecular biology of malignant mesothelioma.
Cancer, Apr-15-2007;109(8):1454-61.
Raz DJ, Jablons DM
Five-gene signature in non-small-cell lung cancer.
The New England journal of medicine, Apr-12-2007;356(15):1582; author reply 1583.
Lin YC, You L, Xu Z, He B, Yang CT, Chen JK, Mikami I, Clément G, Shi Y, Kuchenbecker K, Okamoto J, Kashani-Sabet M, Jablons DM
Wnt inhibitory factor-1 gene transfer inhibits melanoma cell growth.
Human gene therapy, Apr-2007;18(4):379-86.
Clément G, Jablons DM, Benhattar J
Targeting the Wnt signaling pathway to treat Barrett's esophagus.
Expert opinion on therapeutic targets, Mar-2007;11(3):375-89.
Kim J, You L, Xu Z, Kuchenbecker K, Raz D, He B, Jablons D
Wnt inhibitory factor inhibits lung cancer cell growth.
The Journal of thoracic and cardiovascular surgery, Mar-2007;133(3):733-7.
Raz DJ, Glidden DV, Odisho AY, Jablons DM
Clinical characteristics and survival of patients with surgically resected, incidentally detected lung cancer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, Feb-2007;2(2):125-30.
Fujii N, You L, Xu Z, Uematsu K, Shan J, He B, Mikami I, Edmondson LR, Neale G, Zheng J, Guy RK, Jablons DM
An antagonist of dishevelled protein-protein interaction suppresses beta-catenin-dependent tumor cell growth.
Cancer research, Jan-15-2007;67(2):573-9.
Mazières J, Tovar D, He B, Nieto-Acosta J, Marty-Detraves C, Clanet C, Pradines A, Jablons D, Favre G
Epigenetic regulation of RhoB loss of expression in lung cancer.
BMC cancer, 2007;[epublish]7:220.
Kim JY, Harvard C, You L, Xu Z, Kuchenbecker K, Baehner R, Jablons D
Stathmin is overexpressed in malignant mesothelioma.
Anticancer research, 2007 Jan-Feb;27(1A):39-44.
Yagui-Beltrán A, He B, Raz D, Kim J, Jablons DM
Novel therapies targeting signaling pathways in lung cancer.
Thoracic surgery clinics, Nov-2006;16(4):379-96, vi.
[    1  2  3  4  5  6  7  8  9  10  11     View All ]
X